AC ImmuneACIU

AC Immune

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases.

3.4 / 511 reviews
69% recommend to a friend

$196.5M

Market Cap • 02/06/2023

2003

(20 years ago)
Founded

2016

(7 years ago)
IPO

Lausanne

156

Employees 2022

Valuation

Valuation Indicators
YearEquityRevenueEBITDAFin. Res.Net Inc.Net Mar.ROECashDebtN.D. / EBITDAOCFCAPEXFCFFreeDiv.
03/23 TTM1674-730-76LL1153L-73-1-1-740

The values above are represented in USD and the scale is in millions—10.000 is the equivalent of 10 billions. L inside the table means Loss.